CAS: 300802-28-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CA3 - Bio-X REF: IN-DA01EAJ2CAS: 300802-28-2 | % | 51.00 €~486.00 € | Thu 16 Jan 25 |
 | CIL56 REF: TM-T4309CAS: 300802-28-2 | 99.46% - 99.91% | 37.00 €~450.00 € | Thu 23 Jan 25 |
 | CIL56 REF: TR-C433128CAS: 300802-28-2 | - - - | 109.00 €~358.00 € | Tue 28 Jan 25 |
 | CA3 REF: 3D-BC164191CAS: 300802-28-2 | Min. 95% | 324.00 €~904.00 € | Mon 27 Jan 25 |
CA3 - Bio-X
CAS:300802-28-2
Formula:
C23H27N3O5S2
Purity:
%
Color and Shape:
Solid
Molecular weight:
489.6076
Ref: IN-DA01EAJ2
| 10mg | 111.00 € | ||
| 25mg | 155.00 € | ||
| 50mg | 186.00 € | ||
| 100mg | 311.00 € | ||
| 250mg | 486.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
CIL56
CAS:300802-28-2
CIL56 (CA3) is a small molecule that induces cellular ferroptosis through the production of iron-dependent …
Formula:
C23H27N3O5S2
Purity:
99.46% - 99.91%
Color and Shape:
Solid
Molecular weight:
489.61
Ref: TM-T4309
| 1mg | 37.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 113.00 € | ||
| 25mg | 184.00 € | ||
| 50mg | 293.00 € | ||
| 100mg | 450.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
CIL56
Controlled ProductCAS:300802-28-2
Applications CIL56 inhibits YAP/Tead transcriptional activity. Has anti-tumour effects on oesophageal adenocarcinoma with therapeutic potential …
Formula:
C23H27N3O5S2
Color and Shape:
Neat
Molecular weight:
489.61
Ref: TR-C433128
| 1mg | 109.00 € | ||
| 5mg | 219.00 € | ||
| 10mg | 358.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025
CA3
CAS:300802-28-2
Inhibits YAP/Tead transcriptional activity. Has anti-tumour effects on oesophageal adenocarcinoma with therapeutic potential in combination …
Formula:
C23H27N3O5S2
Purity:
Min. 95%
Color and Shape:
White Off-White Powder
Molecular weight:
489.61 g/mol
Ref: 3D-BC164191
| 10mg | 324.00 € | ||
| 50mg | 904.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
